Loading...
Back to narrative

Update shared on17 Oct 2025

Fair value Increased 1.38%
AnalystConsensusTarget's Fair Value
€7.60
9.3% undervalued intrinsic discount
17 Oct
€6.89
Loading
1Y
78.2%
7D
-9.5%

The analyst price target for Piraeus Financial Holdings has been increased from €7.50 to €7.60. Analysts cite improved revenue growth, a slightly lower discount rate, and steady profit margins as justification for the modest upgrade.

Analyst Commentary

Recent updates from major financial institutions highlight growing optimism regarding Piraeus Financial Holdings' outlook. A series of upward price target revisions reflect confidence in the company's execution and growth trajectory.

Bullish Takeaways
  • Bullish analysts continue to raise their price targets for Piraeus Financial Holdings, signaling confidence in sustained earnings momentum.
  • Improved valuation is driven by steady profit margins and robust top-line growth, supporting higher share price expectations.
  • Solid execution and balance sheet stability are viewed as enabling the company to benefit from favorable market conditions.
  • Top-tier institutions such as JPMorgan have issued notable upgrades, citing greater growth potential and maintaining an Overweight stance on the stock.
Bearish Takeaways
  • Some analysts remain cautious about the pace of revenue expansion, noting that upgrades have been incremental rather than drastic.
  • The slightly lower discount rate used in certain models reflects an improved but not risk-free market environment.
  • Sensitivity to macroeconomic shifts persists, as future profit margins may be challenged by broader economic uncertainties.
  • While the consensus is positive, there is acknowledgement that expectations are now higher, raising the bar for future performance.

What's in the News

  • Piraeus Financial Holdings commenced a share repurchase program on September 29, 2025, authorized to buy back up to 27,777,778 shares for €125 million within a price range of €4.5 to €9 per share. The program is valid for 24 months (Key Developments).
  • An Extraordinary Shareholders Meeting was held on September 23, 2025, to amend the share buyback program, consider abolishing the executive stock option plan, and address other corporate matters (Key Developments).
  • The Board of Directors met on May 22, 2025, with the agenda to approve the draft merger agreement (Key Developments).
  • Earnings guidance for 2025 was provided, with expected earnings per share of €0.80 (Key Developments).

Valuation Changes

  • Consensus Analyst Price Target has risen slightly from €7.50 to €7.60. This reflects modest optimism from analysts.
  • Discount Rate has fallen marginally from 11.17% to 11.10%. This indicates a slight reduction in perceived risk.
  • Revenue Growth projections have increased from 2.45% to 2.51%. This points to incremental improvements in the company’s outlook.
  • Net Profit Margin has increased marginally from 43.49% to 43.71%. This suggests stable and strong profitability.
  • Future P/E ratio has edged up from 10.24x to 10.29x. This implies slightly higher earnings expectations relative to price.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.